Live news , top stories, corporate news, company news, sector news, economy news, results analysis news, ceo interviews, fund manager interview, advisor interview, market news, bazaar talk, hot stocks news, ipo news, commodities news, mutual fund news, insurance news, news wire
09 December, 2021 18:09 IST
Hindustan Unilever gets NCLT's nod for merger with GlaxoSmithKline Consumer Healthcare
Source: IRIS | 27 Feb, 2020, 05.25PM
Rating: NAN / 5 stars.
Comments  |  Post Comment

Hindustan Unilever, one of the leading FMCG firms, said the Chandigarh bench of the National Company Law Tribunal (NCLT) has approved its merger with GlaxoSmithKline Consumer Healthcare.

Earlier, on Sep 24, 2019 the National Company Law Tribunal, Mumbai Bench sanctioned the aforesaid scheme, further it was subject to sanction of scheme by the Chandigarh Bench.

''The effective date of the scheme will be communicated upon being finalized by both companies, in accordance with the procedure,'' said the company in a regulatory filling.

Shares of HUL gained Rs 6.95, or 0.31%, to settle at Rs 2,247.90. The total volume of shares traded was 61,938 at the BSE (Thursday).

 Post Comment
Name Email
Comment
Security Code type    into this box
Related Articles
GMM Pfaudler approves ESOP Program for Key Employees - 09-Dec-2021 18:04
Karma Energy to divest entire stake in Batot Hydro Power - 09-Dec-2021 14:24
Venus Remedies receives nod under PLI Scheme - 09-Dec-2021 13:45
Nestle India receives approval under Production Linked Scheme - 08-Dec-2021 20:11
California Software signs MoU to acquire majority stake in Pratsware - 08-Dec-2021 19:43
Alembic Pharmaceuticals gets USFDA nod for Selexipag Tablets - 08-Dec-2021 18:24
ABB India partners with Indore Smart City Development - 08-Dec-2021 17:05
Hero Motocorp expands operations in Argentina - 07-Dec-2021 17:13
Biocon partners with Tabuk Pharmaceuticals - 07-Dec-2021 13:38
Home  |   Shares  |   F&O  |   Mutual Funds  |   Loans  |   Insurance  |   News Centre
Wealth Tracker  |   Newsletters  |   Tax Corner  |   NRI Centre  |   Advertise
© All rights reserved. IRIS Business Services Limited
A Disclaimer